Stage IV Lymphoepithelioma of the Nasopharynx Completed Phase 3 Trials for Amifostine (DB01143)

IndicationStatusPhase
DBCOND0029528 (Stage IV Lymphoepithelioma of the Nasopharynx)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs